Evolution of the Average Target: Satellos Bioscience Inc.

Evolution of the Target Price: Satellos Bioscience Inc.

Changes in Analyst Recommendations: Satellos Bioscience Inc.

900c0a88b4.KXiBaAll_Vo-MnPxhzROBNmLrQIDCB3YLCMWJiLs6vI.bU3ZAUEPnjlsXkHJ2F8LfZfkzkZJMVeyRhVGdFe9moNOPrJbTxDOBXtHGA~6e52fbaadef5e12458baf94a1b396219

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+50.33%
+10.79%
+23.51%
+35.78%
+90.61%
+41.85%
+35.91%
-9.62%
-21.53%
+31.01%
Average +28.86%
Weighted average by Cap. +26.29%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
10.20CAD
Average target price
15.33CAD
Spread / Average Target
+50.33%
High Price Target
19.00CAD
Spread / Highest target
+86.27%
Low Price Target
11.00CAD
Spread / Lowest Target
+7.84%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Guggenheim
Leerink Partners
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
10.20CAD
Average target price
15.33CAD
Spread / Average Target
+50.33%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MSCL Stock
  4. Consensus Satellos Bioscience Inc.